GMILogo_Vertical-Gradient.png
Particle Therapy Market to hit USD 1.7 Bn by 2032, says Global Market Insights Inc.
April 29, 2024 04:30 ET | Global Market Insights Inc.
Selbyville, Delaware, April 29, 2024 (GLOBE NEWSWIRE) -- Particle Therapy Market Size will reach more than USD 1.7 billion by 2032. The surging global burden of cancer is an important trend...
cmi_logo.png
[Latest] Global Golf Training Aids Market Size/Share Worth USD 4.6 Billion by 2033 at a 5.7% CAGR: Custom Market Insights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth, Growth Rate, Value)
April 29, 2024 04:30 ET | Custom Market Insights
Austin, TX, USA, April 29, 2024 (GLOBE NEWSWIRE) -- Custom Market Insights has published a new research report titled “Golf Training Aids Market Size, Trends and Insights By Product Type (Hitting...
Global Space-Qualified Propellant Tank Market
Global Space-Qualified Propellant Tank Industry Research 2023-2033: Burgeoning Opportunities in Modular and Reusable Propellant Tank Systems and Increasing Deep Space Missions
April 29, 2024 04:29 ET | Research and Markets
Dublin, April 29, 2024 (GLOBE NEWSWIRE) -- The "Global Space-Qualified Propellant Tank Market: Focus on Platform, End User, Material, Manufacturing Process, Propellant Tank and Country - Analysis...
Global Cyber weapons Market
Cyber Weapons Industry to Grow by More Than $5 Billion During 2024-2028 - Leading Players are Raytheon Technologies, The Boeing Company, Lockheed Martin, Cisco Systems, and General Dynamics
April 29, 2024 04:01 ET | Research and Markets
Dublin, April 29, 2024 (GLOBE NEWSWIRE) -- The "Cyber Weapons Global Market Report 2024" report has been added to ResearchAndMarkets.com's offering.The global cyber weapons market has grown rapidly...
BGG Logo.jpg
SNOW INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Snowflake Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit!
April 29, 2024 04:00 ET | Bronstein, Gewirtz & Grossman, LLC
NEW YORK, April 29, 2024 (GLOBE NEWSWIRE) -- Attorney Advertising -- Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been...
BGG Logo.jpg
IRBT INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that iRobot Corporation Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit
April 29, 2024 04:00 ET | Bronstein, Gewirtz & Grossman, LLC
NEW YORK, April 29, 2024 (GLOBE NEWSWIRE) -- Attorney Advertising -- Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been...
BGG Logo.jpg
SHLS INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Shoals Technologies Group, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit
April 29, 2024 04:00 ET | Bronstein, Gewirtz & Grossman, LLC
NEW YORK, April 29, 2024 (GLOBE NEWSWIRE) --  Attorney Advertising -- Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has...
ID Logo Medium PNG (Transparent Background).png
InterDigital’s Doug Castor Elected Co-Chair of the ATIS Next G Alliance Steering Group
April 29, 2024 04:00 ET | InterDigital, Inc.
InterDigital’s Doug Castor elected to co-chair the ATIS Next G Alliance Steering Group
Calibre FINAL FILES 72dpi.png
Calibre Scientific Acquires Camlab Limited, a UK Provider of Scientific Equipment, Chemicals, Consumables and Other Laboratory Supplies
April 29, 2024 04:00 ET | Calibre Scientific, Inc.
LOS ANGELES, April 29, 2024 (GLOBE NEWSWIRE) -- Calibre Scientific is pleased to announce the acquisition of Camlab Limited (“Camlab” or the “Company”), a UK-based supplier of scientific equipment,...
selectION Announces Positive Results from Phase 1b Clinical Trial Evaluating si-544 in Patients with Atopic Dermatitis
April 29, 2024 04:00 ET | AKAMPION
si-544 was well tolerated with no serious adverse effects, dose limiting toxicities, or safety signals observed75% of patients receiving si-544 experienced objective clinical improvement, of which 44%...